IDLinks

ALAN D. TICE, M.D., FACP

Infections Limited Hawaii

---

EDUCATION

Fellowship in Infectious Diseases (Louis Weinstein), New England Medical Center,
     Tufts University, 1973-1975
Residency in Internal Medicine, Manhattan Veterans Administration Hospital,
     New York University, 1972-1973
Internship and Residency in Internal Medicine, The Roosevelt Hospital,
     Columbia University, 1970-1972
Columbia College of Physicians and Surgeons, M.D., 1970
Harvard College, B.A. (Magna Cum Laude), Henley Crew1966

 

PROFESSIONAL EXPERIENCE

2006 - Present	City and County of Honolulu, Designated Officer for Infectious Diseases - Emergency Medical Services, Honolulu Fire Department, Honolulu Police Department
2005 - 2008	Flagship Global Health - Regional Medical Director
2001 - Present	Resident clinic at Queen Emma Clinic, Community Clinics at Waikiki Health Center, and Kalihi-Palama
2001 - Present	Medical Staff - Queen’s Medical Center, Hawaii Medical Centers, Kuakini Hospital, and Straub Hosptal, Honolulu, Hawaii
2001 - Present	Infections Limited Hawaii - Consultant and Practitioner, Honolulu, Hawaii
2001 - Present	John A. Burns School of Medicine, University of Hawaii at Manoa Associate Professor, Department of Internal Medicine Curriculum Committee
2000- Present	Queens Medical Center, Honolulu, Hawaii Infection Control Committee - 2005-present Antibiotic Use Committee – 2003-2009 Wound Care Center – 2005-2008
1986 - Present	Outpatient Parenteral Antimicrobial Therapy (OPAT) OutcomesRegistry Founder and Director
1980 - 2001	University of Washington - Clinical Associate Professor Department of Infectious Diseases
1978 - 2001	Infections Limited, P.S. - Founder and Partner, Tacoma, WA Infectious Diseases clinic with microbiology laboratory, clinical research, outpatient intravenous antibiotic therapy, travelers’ clinic, and tuberculosis clinic Associates: Peter K. Marsh, Philip C. Craven, David W. McEniry, Lawrence E. Schwartz, James DeMaio
1975 - 1978	Brown University Program in Medicine – Assistant Professor Chief of Infectious Diseases, Providence VA Hospital

 

AWARDS AND HONORS

 

PUBLICATIONS(SELECTED)

• Zeuzem S, Sulkowski MS, Lawitz EJ, Rustgi VK, Rodriguez-Torres M, Bacon BR, Grigorescu MD, Tice AD, Lurie Y, Cianciara J, Muir AJ, Cronin PW, Pulkstenis E, Subramanian GM, McHutchison JG; ACHIEVE-1 Study Team.Randomized Trial of albinterferon alfa-2b for the Treatment of Patients With Chronic Hepatitis C Virus Genotype 1.Gastroenterology. 2010 Jul 2. [Epub ahead of print]PMID: 20600013 [PubMed - as supplied by publisher]
  
• Ciccarone RM, Kim M, Tice AD, Nakata M, Effler P, Jernigan DB, Cardo DM, Sinkowitz-Cochran RL.Prevention of community-associated methicillin-resistant Staphylococcus aureus infection among Asian/Pacific Islanders: a qualitative assessment.Hawaii Med J. 2010 Jun;69(6):142-4.PMID: 20535687 [PubMed - in process]
  
• Logman JF, Stephens J, Heeg B, Haider S, Cappelleri J, Nathwani D, Tice A, van Hout BA.Comparative effectiveness of antibiotics for the treatment of MRSA complicated skin and soft tissue infections.Curr Med Res Opin. 2010 Jul;26(7):1565-78.PMID: 20429820 [PubMed - in process]
  
• Tice AD, Bannan M, Bauman K, Collis T, Hall A, Haning W, Hannemann S, Hare CB, Humphry J, Jao R, Leevy C, Lusk H, Ochoa E, Palafox N, Withers N, MPH, Akinaka KT VIRAL HEPATITIS IN HAWAI'I - DIFFERING PERSPECTIVES. Hawaii Med J 2010; April, vol. 69(4);Supplement 1 ISSN:0017-8594.
  
• Tice AD, Pombo D, Hui J, Kurano M, Bankowski MJ, Seifried SE.Quantitation of Staphylococcus aureus in seawater using CHROMagar SA.Hawaii Med J. 2010 Jan;69(1):8-12.PMID: 20222490 [PubMed - indexed f
  
• Suwantarat N, Tice AD, Khawcharoenporn T, Chow DC.Weight loss, leukopenia and thrombocytopenia associated with sustained virologic response to Hepatitis C treatment.Int J Med Sci. 2010 Jan 22;7(1):36-42.PMID: 20107528 [PubMed - indexed for MEDLINE]Free PMC ArticleFree text
  
• Pangilinan R, Tice A, Tillotson G Topical antibiotic treatment for uncomplicated skin and skin structure infections: review of the literature.Expert Rev Anti Infect Ther. 2009 Oct;7(8):957-65. Review.PMID: 19803705
  
• Boyce, DEC, Tice AD, Ona FV, Akinaka KT, Lusk H. Viral hepatitis in a homeless shelter in Hawaii. Hawaii Med J 2009; June, vol. 68(5);113-5.
  
• Chow D, Okinaka L, Souza S, Shikuma C, Tice A. Hansen’s Disease with HIV: a case of immune reconstitution disease. Hawaii Med J  2009; Mar 68(2):27-9.
  
• Tice AD, Khawcharoenporn T, Chow D. Beta-lactam antibiotics no longer appropriate for cellulitis. Am J Med 2008; Nov 121(11):e11.
  
• Bonkovsky HL, Tice AD, Yapp RG, Bodenheimer HC Jr, Monto A, Rossi SJ, Sulkowski MS. Efficacy and safety of peginterferon alfa-2a/ribavirin in methadone maintenance patients: randomized comparison of direct observed therapy and self-administration. Am J Gastroenterol, 2008; Nov 103(11):2757-65. Epub 2008 Aug 5.
  
• Morita JE, Fujioka RS, Tice AD, Berestecky J, Sato D, Seifried SE, Katz AR. Survey of methicillin-resistant Staphylococcus aureus (MRSA) carriage in healthy college students, Hawai’i. Hawaii Med J 2007; Aug 66(8):213-5.
  
• Marineau M, Tice AD, Taylor-Garcia D, Akinaka KT, Lusk H, Ona F. Culturally Sensitive strategies designed to target the silent epidemic of hepatitis B in a Filipino community. Hawaii Med J 2007; Jun 66(6):154-6.
  
• Tice AD, Turpin RS, Hoey CT, Lipsky BA, Wu J, Abramson MA. Comparative costs of ertapenem and piperacillin-tazobactam in the treatment of diabetic foot infections. Am J Health Syst Pharm 2007; May 15:64(10):1080-6.
  
• Brown JD, Kangwanprasert M, Tice A, Melish J. Thyrotoxin periodic paralysis in a Polynesian male following highly active antiretroviral therapy for HIV infection. Hawaii Med J 2007; Mar 66(3):60, 62-3
  
• Lipsky BA, Sheehan P, Armstrong DG, Tice AD, Polis AB, Abramson MA. Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial. Int Wound J 2007; Mar 4(1):30-8.
  
• Yamauchi T, Tice A. Metabolic abnormalities with atypical antipsychotics: a case report and alert. Hawaii Med J 2007; Jan 66(1):12-3.
  
• Seifried SE, Tice AD, Eischen M. Diversity community-associated strains of methcillin-resistant Staphylococcus aureus in Hawaii. J Infect Dis 2007; Jan 15:195(2):305; author reply 305-7.
• Koenigsfeld CF, Tice AD. Organizing a community advanced pharmacy practice experience.
  Am J Pharm Educ 2006; Feb 15:70(1):22.
  
• Chary A, Tice AD, Martinelli LP, Liedtke LA, Plantenga MS, Strausbaugh LJ. Experience of infectious diseases consultants with outpatient parental antimicrobial therapy: results of an emerging infections network survey. Clin Infect Dis 2006; Nov 15:43(10):1290-5. Epub 2006 Oct 10.
  
• Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE. S. aureus endocarditis and bacteremia study group. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006; Aug 17:355(7):653-65.
  
• Tice AD, Kishimoto M, Dinh CH, Lam GT, Marineau M. Knowledge of severe acute respiratory syndrome among community physicians, nurses, and emergency responders. Prehosp Disaster Med 2006; May/Jun 21(3):183-9.
  
• Alden DL, Tice AD, Berthiaume JT. Antibiotics and upper respiratory infections: The impact of Asian and Pacific Island ethnicity on knowledge, perceived need, and use. Ethnicity and Disease 2006; 16:268-74.
• Lipsky BA, Armstrong DG, Citron DM, Tice AD, Morgenstern DE, Abramson MA. Ertapenem versus pipericillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomized, controlled, double-blinded, muticentre trial. Lancet 2005; Nov 366:1695-1703 .
• Yanagihara DM, Taira DA, Davis J, Gronley KA, Marciel C, Lee E, Tice AD. A health plan intervention to improve pneumococcal vaccination in the elderly. Managed Care Interface 2005; September vol 18, no 9, pp25-30.
• Wynn J, Dlaovisio JR, Tice AD, Jiang X. Evaluation of the efficacy and safety of outpatient parenteral antimicrobial therapy for infections with methicillin-sensitive Staphylococcus aureus. Southern Medical Journal 2005; June 98(6):590-5.
  
• Tice AD. Managing Methicillin-Resistant Staphylococcus aureus. Infectious Diseases Special Edition 2004; 7:43-5.
• Tice AD, Rehm SJ, Dalovisio JS, Bradley JS, Martinelli LP, Graham DR, Gainer RB, Kunkel MJ, Yancey RW, Williams DN. Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy. Clin Infect Dis 2004; June 38:1651-72
• Tice AD. Ertapenem: A new opportunity for outpatient parenteral antimicrobial therapy. J Antimicrob Chemother 2004; June 53: ii83-ii86
• Tice AD, Bhan R. PDAs for the infectious diseases physician. Inf Dis Clin Prac 2003; 11(7):390-396
  
• Tice AD, Hoaglund PA, Shoultz DA. Risk factors and treatment outcomes in osteomyelitis. J Antimicrob Chemother 2003; 51(5):1261-6

• Small EA, Tice AD. Internal Parasites of the Pacific. Hawaii Medical Journal 2003; Oct; 62:216-19.

• Tice AD, Bhan R. PDAs for the Infectious Diseases Physician. Inf Dis Clin Prac 2002; 11(7):390-6.

• Tice AD. Community-Acquired Pneumonia: Recent Insights Into an Old Disease. Infect Med 2003; 20(7):352-356

• Tice AD, Hoaglund PA, Shoultz DA. Outcomes of osteomyelitis with outpatient parenteral antimicrobial therapy. Am J Med 2003; 114:723-28.

• Eron LJ, Lipsky BA, Low DE, Rahal JJ, Tice AD, Volturo GA. Key Decision Points in Evaluating and Trating Cellulitis – Expert panel recommendations on managing cellulites from hospital to home. Home Health Care Consultant 2002; Suppl. July: 1-12

• Tice AD, Strait K, Tice ACC. The Market for Infectious Diseases Specialists. Inf Dis Clin Prac 2002; 11:193-97.

• Tice AD. Bloodborne Pathogen Exposure and Recommendations for Management. Jounal of Infusion Nursing 2002; Nov/Dec 25(6S):S5-S9.

• Tice AD, Hoaglund PA, Nolet B, et. al. Cost Perspective for Outpatient Intravenous Antimicrobial Therapy Pharmacotherapy 2002; Feb;22(2 Pt 2):63S-70S.

• Nathwani D, Tice A. Ambulatory antimicrobial use: the value of an outcomes registry. J Antimicrob Chemother 2002; Jan 49(1):149-54.

• Tice AD, Nolet BR. Update on outpatient parenteral antimicrobial therapy. Home Healthcare Consultant 2001; 8:22-9.

• Tice AD, DeMaio JD, Cruz-Uribe F, et.al. Tuberculosis Control: A Cooperative Public and Private Model. Inf Dis Clin Prac 2001; 10:361-65.

• Tice AD. The Use of Outpatient Parenteral Antimicrobial Therapy in the Management of Osteomyelitis: Data from the Outpatient Parenteral Therapy Outcomes Registries. Chemotherapy 2001; Nov;47 Suppl SI:5-16.

• Tice AD. Outpatient parenteral antimicrobial therapy (OPAT): a global perspective. Introduction. Chemotherapy 2001; 47 Suppl S1:1-4.

• DeMaio J, Schwartz L, Cooley P, Tice A. The application of telemedicine technology to a directly observed therapy program for tuberculosis: A pilot program. Clin Infect Dis. 2001; Dec 15:33(12):2082-84
• Tice AD, DeMaio JD, Cruz-Uribe F, et.al. Tuberculosis control: A cooperative public and private model. Inf Dis Clin Prac 2001; 10:361-5
• Tice AD. Pharmacoeconomic considerations in the ambulatory use of parenteral cephalosporins. Drugs 2000; 59 Suppl 3:29-35.
• Tice AD. Documenting the value of OPAT: Outcome studies and patient registries. Can J Infect Dis 2000; Jan/Feb 11A:45A-48A
• Tice AD. Outpatient Parenteral Antibiotic Therapy (OPAT) in the United States: Delivery models and indications for use. Can J Infect Dis 2000; Jan/Feb 11A: 17A-21A

• Tice AD, Schleis TG, Nolet BN, et al. Outcomes registry for outpatient IV antimicrobial therapy. Infusion 2000; May 6(7):27-35.

• Luna VA, Jernigan DB, Tice, AD, et al. A Novel Multiresistant Streptococcus pneumoniae Serogroup 19 Clone from Washington State Identified by Pulsed-Field Gel Electrophoresis and Restriction Fragment Length Patterns. J Clin Microbial 2000; Apr 38(4):1575-80.

• Tice AD. Pharmacoeconomic Considerations in the Ambulatory Use of Parenteral Cephalosporins. Drugs 2000; 59 Suppl 3:29-35.

• Tice AD. Documenting the Value of OPAT: Outcome Studies and Patient Registries. Can J Infect Dis 2000; Jan/Feb 11A:45A-48A.

• Tice AD. Outpatient Parenteral Antibiotic Therapy (OPAT) in the United States: Delivery Models and Indications for Use. Can J Infect Dis 2000; Jan/feb 11A: 17A-21A.

• Tice AD, Strait K, Ramey R, Hoaglund PA. Outpatient Parenteral Antimicrobial Therapy for Central Nervous System Infections. Clin Infect Dis 1999; Dec 29(6):1394-9.

• Baumgarten K, Tice AD, Pankey GA. An unconscious ex-fighter pilot. Infec Med. 1999; 16:710-714.

• Echols RM, Tosiello RL, Haverstock DC, Tice AD. Demographic, Clinical, and Treatment Parameters Influencing the Outcome of Acute Cystitis. Clin Ther 1999; July 29:113-19.

• Henry DC, Nenad RC, Irvani A, Tice AD. Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. Clin Ther 1999; June; 21(6):966-81.

• Tice AD. Short-Course Therapy of Acute Cystitis: A Brief Review of Therapeutic Strategies. Journal of Antimicrobial Chemotherapy 1999; 43, Suppl A, 85-93RM.

• Sexton DJ, Tenenbaum MJ, Wilson WR, Steckelberg JM, Tice AD, et al. Ceftriaxone Once Daily for Four Weeks Compared with Ceftriaxone Plus Gentamicin Once Daily for Two Weeks for Treatment of Endocarditis Due to Penicillin-Susceptible Streptococci. Clin Inf Dis 1998; Dec 27:1470-1474.

• Tice AD. Outpatient Parenteral Antimicrobial Therapy for Osteomyelitis. Inf Dis Clin of North America 1998; Dec 12:4 903-19.

• Tice AD. Outpatient Parenteral Antibiotic Therapy for Fever and Neutropenia. Inf Dis Clin of North America 1998; Dec. 12:4 963-77.

• Tice AD. Medicare Coverage of Outpatient Ambulatory Intravenous Antibiotic Therapy: A Program that Pays for Itself. Clin Inf Dis 1998; Dec 27:1415-21.

• Tice AD. Outpatient parenteral antimicrobial therapy as an alternative to hospitalization. IJCP Supplement 1998; March 1-5.

• Williams DN, Rehm SJ, Tice AD, et al. Practice guidelines for community-based parenteral anti-infective therapy. Clin Inf Dis 1997; Oct 25:4 787-801.

• Tice AD, Nolet BR. Lessons in Managed Care. Inf Dis Clin Prac 1997; Aug 6:6 374-77.

• Tice AD. Osteomyelitis. Outpatient Parenteral Antimicrobial Therapy: Current Status. Scientific American Medicine Special Edition 1997; Jul 55-9.

• Tice AD, Nolet BR, Schleis, T. The OPAT Team. Outpatient Parenteral Antimicrobial Therapy: Current Status. Scientific American Medicine Special Edition 1997; Jul 19-21.

• Tice AD. The office/clinic model for OPAT. Outpatient Parenteral Antimicrobial Therapy: Current Status. Scientific American Medicine Supplement 1997; Jul 12-14.

• Tice AD, Nolet BR. Delivery models for outpatient parenteral antimicrobial therapy. Outpatient Parenteral Antimicrobial Therapy: Current Status. Scientific American Medicine Special Edition 1997; Jul 7-11.

• Schwartz LE and Tice AD. Streptococcal pharyngitis.  In Conn’s Current Therapy. W.B. Saunders Company. HF Conn and others. (Eds) 1997; 237-39.

• Hadlock C, Niederman MS, Stelmach WJ, Brown RB, Tice AD, Bartlett JG. Clinical pathways in an acute care setting: community-acquired pneumonia. Inf Dis Clin Pract 1996; Dec Suppl 4: S166-S74, discussion S174-S178.

• Tice AD. Outpatient parenteral antibiotic therapy in different countries. Int J of Inf Dis 1996; Nov 1:2 102-6.

• Marsh PK, Tice AD, Craven PC, McEniry DW, Sullivan ME. Imipenem/cilastatin therapy in the management of infections in the outpatient setting. Inf Dis Clin Pract. 1996; 5:498-501.

• Tice AD, Slama TG, Berman S, et al. Managed care and the infectious diseases specialist. Clin Inf Dis. 1996; Aug 23:2 341-68.

• Tice AD. Alternate site infusion: the physician-directed, office-based model. J Intraven Nurs. 1996; Jul-Aug 19:4 188-93.

• Schleis TG, Tice AD. Selecting infusion devices for use in ambulatory care. Am J Health Syst Pharm 1996; Apr 53:8 868-77.

• Tice AD. Simple infusion devices for home and outpatient administration of intravenous antibiotics. American Academy of Home Care Physicians 1995; (3):9-11.

• Tice AD. Patient selection criteria for outpatient parenteral antibiotic therapy - experiences with a physician-directed, clinic-based program in the USA. Eur J Clin Microbiol Inf Dis. 1995; Jul 14:7 655-61.

• Tice AD. The importance of teamwork for outpatient parenteral antibiotic therapy. Inter J Antimicrob Agents. 1995; 5:13-17.

• Tice AD, Shulkin DJ. Treatment of a patient with osteomyelitis - studies in costeffective care-giving. Hospital Physician. 1995; Jan  31:1 40-2.

• Iravani A, Tice AD, McCarty J, Sikes DH, et al. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women: the minimum effective dose. Arch Intern Med. 1995; Mar 155: 5 485-494.

• Tice AD. Management of serious infections. Part II: Amenable infections and models for delivery Osteomyelitis. Hosp Pract (Off Ed) 1993; Jul 28 Suppl 2: 36-39, discussion 57-8.

• Tice AD. Management of serious infections. Part I: Medical, socioeconomic, and legal issues. The team concept. Hosp Pract (Off Ed) 1993; Jun  28 Suppl 1: 6-10.

• Tice AD, Bonstell RP, Marsh PK, Craven PC, McEniry DW, Harding S. Peripherally inserted central venous catheters for outpatient intravenous antibiotic therapy. Inf Dis Clin Pract 1993; 2:186-90.

• Tice AD. Fungal diseases. 1992 Medical and Health Annual, Encyclopaedia Britannica. Chicago, Encyclopaedia Britannica Inc., Bernstein, E., (Ed) 1992; 479-83.

• Tice AD. Ceftriaxone in treatment of serious infections. Osteomyelitis. Hosp Pract. 1991; Sep. Suppl 5: 31-36, discussion 57-8.

• Tice AD. Once-daily ceftriaxone outpatient therapy in adults with infections.  Chemotherapy. 1991 37 Suppl 3: 7-10.

• Richet HM, Craven PC, Brown JM, Lasker BA, Cox CD, McNeil WM, Tice AD, Jarvis MR, Tablan OC.  A cluster of Rhodococcus (gordona) bronchialis sternal-wound infections after coronary artery bypass graft surgery. N Eng J Med. Jan 1991 324:2 104-109.

• Tice AD.  An office model for outpatient parenteral antibiotic therapy. Rev of Infect Dis. 1991; Jan-Feb 13 Suppl 2: S184-8.

• Tice AD. Once-daily ceftriaxone outpatient therapy in adults with infections. Chemotherapy 1991; Jan-Feb;37 Suppl 3:7-10.
  

• Tice AD, Marsh PK, Craven PC. Comparison of intravenous ciprofloxacin with ceftazidime in the treatment of serious soft tissue infections. Diag Microbiol Infect Dis. 1990; Mar-Apr.  13(2) 165-7.

• Tice AD. Infectious Diseases 1990 Medical and Health Annual, Encyclopaedia Britannica. Chicago, Encyclopaedia Britannica Inc., Bernstein, E., (Ed.) 1990; 336-341.

• Tice AD. Infectious Diseases 1989 Medical and Health Annual, Encyclopaedia Britannica. Chicago, Encyclopaedia Britannica Inc., Bernstein, E., (Ed.) 1989; 336-341.

• Tice AD. Acquired immune deficiency syndrome. 1988 Medical and Health Annual, Encyclopaedia Britannica Inc. Chicago, Encyclopaedia Britannica Inc., Bernstein,E., (Ed.) 1988; 336-41.

• Greenberg RN, Tice AD, Marsh PK, Craven PC, Reilly PM, Bollinger M, Weinandt WJ. Randomized trial of ciprofloxacin compared with other antimicrobial therapy in the treatment of osteomyelitis. Am J Med  1987; Apr 82:4A 266-9.

• Gilbert DN, Tice AD, Marsh PK, Craven PC, Preheim LC. Oral ciprofloxacin therapy of chronic contiguous osteomyelitis due to aerobic gram-negative bacilli. Am J Med 1987; Apr 82:4A 254-8.

• Holmes KK, Tice AD. Infectious Diseases (Contempo Issue) JAMA 1986; 256:2093-4.

• Tice AD. Infections and the spleen. Tacoma Quarterly Med Rev 1985; 1:25-30.

• Tice AD. Bites and bite-related infections. In Current Pediatric Therapy. (9^th ED.  687-689). Philadelphia, PA: Gellis and Kagan, 

• Ho G Jr, Tice AD. Comparison of non-septic and septic bursitis. Further observations on the treatment of septic bursitis.  Arch Intern Med 1979; Nov 139:11 1269-73.

• Smith JW, Jones SR, Reed WP, Tice AD, Deupree RN, Kaijser B. Recurrent urinary tract infections in men. Characteristics and response to therapy. Ann Intern Med 1979; Oct 91(4): 544-48.

• Tice AD, Solomon RJ. Disseminated Mycobacterium chelonei infection: response to sulfonamide. Am Rev Respir Dis 1979; Jul 101:1197-202. 

• Tice AD, Nelson J, Visconti EB. Listeria monocytogenes pericarditis and myocardial abscess.  R I Med J 1979; Apr 62:4 135-8.

• Tice AD, Oh W. Anaerobic osteomyelitis due to Propionibacterium acnes.   J Orthopedic Rev 1978; 7:67-9.

• Ho G Jr, Tice AD, Kaplan SR. Septic bursitis in the prepatellar and olecranon bursae: an analysis of twenty-five cases.   Ann Intern Med 1978; Jul 89:1 21-7.

• Greene DS, Tice AD. Effects of hemodialysis on cefazolin protein binding.   J Pharm Sci  1977; Oct 66:10 1508-10.

• Tice AD, Barza M, Bergeron MC, Brusch JD, Weinstein L. Effects of diuretics on the urinary excretion of cephalothin in man.   Antimicrob Agents Chemother 1975; Feb 7:2 168-71.
• Weiss HJ, Berger RE, Tice AD, Phillips LL. Fatal disseminated intravascular coagulation and hemolytic anemia following stibophen therapy. Am J Med Sci 1972; Nov 264:5 372-84.

• Tice AD. (2007). Swimming with Staphlococci at Waikiki. Infectious Disease News. Nov, p93.

• Tice AD. (2005). Commentary: The Future of Parental Antibiotics. Infection Disease Special Edition.  8, p. 94.

• Tice AD. (2004). Managing Methicillin-Resistant Staphylococcus aureus. Infectious Diseases Special Edition. 2004 7:43-45
  

• Ongkarn S, Suwantarat N, Tice AD, Arakaki RF. (January 2009). The Effect of Antiviral Therapy in Chronic Hepatitis C: Improvement in fasting Plasma Glucose Levels in Patients with Impaired fasting Glucose. Annual Meeting of Hawaii Chapter of the American College of Physicians. Kaneohe, HI.
  
• Boyce DEC, Tice AD, Ona, FV, Akinaka KT, Lusk H. (January 2009). Viral Hepatitis in a Homeless Shelter in Hawaii. Annual Meeting of Hawaii Chapter of the American College of Physicians. Kaneohe, HI.
• Suwantarat N, Mullen C, Howman S, Tice AD. (January 2009). Necrotizing Fasciitis: Incidence, Mortality, Risk Factors and Microbiological Profile Among Patients in Hawaii. Annual Meeting of Hawaii Chapter of the American College of Physicians. Kaneohe, HI.
• Suwantarat N, Tice AD, Khawcharoenporn T, Chow DC. (October 2008). Weight Loss, Leukopenia, and Thrombocytopenia Associated with Sustained Virologic Response to Hepatitis C Treatment.  Poster #V-1635, 46th Annual Meeting of the IDSA, Washington DC. 
  
• Khawcharoenporn T, Tice AD. (October 2008). Empiric Oral Antibiotic Therapy with Trimethoprim-sulfamethoxazole, Cephalexin, or clindamycin for outpatients with cellulitis. Poster #L-1497, 46th Annual Meeting of the IDSA, Washington DC.
• Stephens JM, Treur MJ, Heeg BM, Haidr S, Nathwani D, Tice AD. (October 2008). Inpatient and Outpatient Cost Model of Treating Gram+ Complicated Skin and Soft Tissue Infections (cSSTIs)  Poster #K-3491, 46th Annual Meeting of the IDSA, Washington DC.
• Khawacharoenporn T, Tice AD. (January 2008).  Evaluation of Empiric Oral Antibiotic Treatment for Outpatients with Cellulitis in a Community with a high prevalence of Community-associated Methicillin-resistant Staphylococcus aureus (CA-MRSA) Infections. Annual Meeting of Hawaii Chapter of the American College of Physicians. Kaneohe, Hawaii.
• Suwantarat N, Khawcharoenporn T, Tice AD. (January 2008). Treatment Outcome Among Hepatitis C in Hawaii. Annual Meeting of Hawaii Chapter of the American College of Physicians. Kaneohe, Hawaii.
• Pangilinan R,  Tice AD, Tillotson G. (January 2008). Topical Antibiotic Treatment for Uncomplicated Skin and Structure Infections: Review of the Literature. Annual Meeting of Hawaii Chapter of the American College of Physicians. Kaneohe, Hawaii.
• Jinno, S, Seifred, S, Bankowski, M. Tice, A. (January 2008) What are the Virulence Factors that Enable Staphylococcus aureus to Cause Blood Stream Infection? Annual Meeting of Hawaii Chapter of the American College of Physicians. Kaneohe, Hawaii.

• Tice AD, Fowler TL, Fujioka RS. (October 2004). Staphylococcus aureus in the Recreational Seawaters of Hawaii. Poster 56. 42nd annual meeting of the Infectious Diseases Society of America, Boston, MA.

• Tice AD, Seibold GL, Martinelli LP. (October 2003). Reasons for Failures with OPAT. Poster #293. 41st Annual Meeting of the IDSA, San Diego, CA.

• Tice, AD, Seibold GL, Martinelli LP, Nathwani D. (October 2003). OPAT Outcomes Registry Evaluation of Diabetic Extremity Infections. Poster #291. 41st Annual Meeting of the IDSA, San Diego, CA.

• Berthiaume JT, Pang R, Taira D, Tice A, Chung R. (October 2002). Impact of Intervention by a Health Insurer Regarding Oral Antimicrobial Prescribing. Poster #596. 40th Annual Meeting of the IDSA, Chicago, IL.

• Tice AD, Seibold GL, Martinelli LP. (October 2002). Adverse Effects from Intravenous Antibiotics with OPAT. Abstract 59. 40th Annual Meeting of the IDSA, Chicago, IL.

SATELLITE SYMPOSIUMS

• Tice AD -  Managing MRSA in Diverse Milieu: Case Studies in Emergency Room, Surgery, and Outpatient Settings Capitalizing on what we Know about Gram-Positive Organisms – Three bad bugs – the Battle Continues. 46th Annual Meeting of the IDSA, Washington DC, 2008.
  

• Allo Mandell Book (2009)

• Tice AD. (2005). Outpatient Parenteral Antimicrobial Therapy. Mandell GL, Bennett JE, Dolin R (Eds).  Principles and Practice of Infectious Diseases, (6th ed.), pp. 629-633. Churchill Livingstone, Elsevier Health Sciences .
  

• Tice AD, Kelly J. (2005). Antibiotic Optimization – Strategies in Clinical Practice (Chapter 18) pp 553-575. Outpatient Parental Antimicrobial Therapy: Role in Optimizing Length of Hospital Stay. Marcel Dekker, New York.
  

• Bower J, Segarra-Newnham M, Tice AD. (2004) In Mayhall CD (EDs.), Hospital Epidemiology and Infection Control. (3rd ed.) pp. 161-175. Lippincott, Williams & Wilkins.

• Tice AD. (2000) Home health care. In: Abrutyn E, Goldmann DA, Scheckler WE (EDs.). Saunders Infection Control Reference Service. (2^nd ed.), pp. 151-154 W.B. Saunders Company

• Tice AD. (2000) Outpatient Intravenous Antibiotic Therapy. Mandell GL, Bennett JE, Dolin R (EDs.), Principles and Practice of Infectious Diseases, pp. 546-550. Churchill Livingston, Harcourt Health Sciences.

• Tice AD. (1999) Home Therapy with Antibiotics. In Armstrong D and Cohen J  (EDs.), Infectious Diseases. pp. 4.1-4.4 Harcourt Publishers Ltd.

• Tice AD. (1999) Outpatient Parenteral Therapy of Serious Infections. Root RK, Waldvogel F, Corey L, Stamm WE (EDs.), Clinical Infectious Diseases: A Practical Approach. pp.241-44 New York: Oxford University Press, Inc. 

• Tice AD. (1980) Bites and bite-related infections. Current Pediatric Therapy. (9th Ed.). Philadelphia, PA: Gellis and Kagan.